semaglutide type 1 diabetes randomized trial 2024 SELECT New advances in type 1

A key update from the ADA is the integration of a formal risk assessment ( below ) to identify high-risk patients, particularly those with impaired awareness of hypoglycemia or a recent history of severe events

GLP-1 medications typically produce: Lower postprandial glucose peaks (post-meal spikes become flatter and shorter) Reduced fasting glucose over time as weight decreases Improved Time in Range (TIR) the percentage of time your glucose stays between 70180 mg/dL, which is the key CGM metric for diabetes management Because the oral pill is taken daily rather than weekly, the GLP-1 effect on gastric emptying may be more consistent throughout the week though individual CGM patterns will vary

Now, you might be thinking, "Injections

Without these habits, weight regain is possible

Achieving Target Weight Patients who have reached their target weight and maintained it for a stable period (typically six months or more) may consider weaning down treatment